自评报告
博硕士生导师
当前位置: 首页 >> 师资队伍 >> 博硕士生导师

药学院硕士研究生导师--任国莲

日期:2021年11月24日 16:48 作者:来源: 点击数:

导师介绍

 

任国莲

性别

出生年月

19799

13C95

学历学位

博士研究生

政治面貌

中共党员

研究方向

新型纳米递药系统与药物代谢动力学研究

工作单位

山西医科大学药学院

通讯地址

山西省太原市新建南路56

glren2007@126.com

学习经历:

2012/09-2016/06,沈阳药科大学,中药学院,中药学,博士

2003/09-2006/06,山西医科大学,药学院,药剂学,硕士

1998/09-2002/07,山西医科大学,药学院,药学,学士

工作经历:

2019-01至现在,山西医科大学,药学院,副教授

2019-012019-12,美国宾夕法尼亚州,匹兹堡大学,药学院,访问学者

2010-012018-12,山西医科大学,药学院,讲师

2007-062009-12,山西医科大学,药学院,助教

主持省级项目4项,主持校级项目3项;参与国家级项目2项,参与省级项目5项;以第一/通讯作者发表高水平学术论文10篇。

代表性

 

1. Wenju Guo†, Ning Li†, Guolian Ren*,   RongRong Wang, Liqin Chai, Yujie Li, Xi Wang, Shuai Duan, Jiaqi Tang,   Qingshan Yang, Guoshun Zhang, Xiaoqing Shang, Hengtong Zuo, Bofang Yi, Yuwei   Wang and Shuqiu Zhang*. Pharmacokinetics and antimalarial pharmacodynamics of   dihydroartemisinin trimer self-assembled nanoparticles in murine.   Parasitology Research, 2021, 120 (8), 2827-2837.

2. Rongrong Wang, Guolian Ren*, Liqing   Chai, Wenju Guo, Yujie Li, Ruili Wang, Yongdan Zhao, Shuqiu Zhang*.   Pharmacokinetics and antimalarial activities of reduction-responsive   releasing dihydroartemisinin prodrug self-assembled nanoparticles in rodents.   Journal of Drug Delivery Science and Technology, 2021, 63, 102515.

3. Ruili Wang#, Guangyu Shi#, Liqing Chai,   Rongrong Wang, Guoshun Zhang, Guolian Ren*, Shuqiu Zhang*. Choline and   PEG dually modified artemether nano delivery system targeting   intra-erythrocytic plasmodium and its pharmacodynamics in vivo. Drug   Development and Industrial Pharmacy, 2021, 47 (3): 454-464.

4. Guolian Ren, Pei Chen, Jiaqi Tang, Wenju Guo, Rongrong   Wang, Ning Li, Yujie Li, Guoshun Zhang, Ruili Wang and Shuqiu Zhang*. In   vivo and in vitro evaluation of dihydroartemisinin prodrug   nanocomplexes as a nano-drug delivery system: characterization,   pharmacokinetics and pharmacodynamics. RSC advances, 2020, 10, 17270-17279.

5. Ning Li, Wenju Guo, Yujie Li, Hengtong Zuo,   Huihui Zhang, Zhaoyun Wang, Yongdan Zhao, Fan Yang, Guolian   Ren* and Shuqiu   Zhang*. Construction and Anti-Tumor Activities of Disulfide-Linked   Docetaxel-Dihydroartemisinin Nanoconjugates. Colloids and Surfaces B:   Biointerfaces, 2020, 191,111018.

6. Shuai Duan, Ruili Wang,   Rongrong Wang, Jiaqi Tang, Xiaoyang Xiao, Ning Li, Wenju Guo, Qingshan Yang, Guolian   Ren* and Shuqiu Zhang*. In vivo   antimalarial activity and pharmacokinetics of artelinic acid-choline   derivative liposomes in rodents. Parasitology, 2020, 147(1):58-64.

7. Guolian Ren,   Pei Chen, Jiaqi Tang, Rongrong Wang, Shuai Duan, Ruili Wang, Yin Xie*, and Shuqiu Zhang*. Construction and cellular uptake evaluation of   redox-responsitive docetaxel prodrug self-assembled nanoparticles. Drug   Development and Industrial Pharmacy, 2018, 44(4):598-607.

8. Guolian Ren,   Mengjuan Jiang, Weiling Guo, Bingjun Sun, He Lian, Yongjun Wang and Zhonggui   He. Construction and cellular uptake behavior of   redox-sensitive docetaxel prodrug-loaded liposomes. Pharmaceutical   Development and Technology, 2018, 23(1):22-32.

9. Guolian Ren, Mengjuan Jiang, Peng Xue, Jing Wang, Yongjun   Wang, Bo Chen, Zhonggui He. A unique highly hydrophobic anticancer prodrug   self-assembled nanomedicine for cancer therapy. Nanomedicine:   Nanotechnology, Biology, and Medicine, 2016,12(8):2273-2282.

10. GuoLian Ren, Dan   Liu, Weiling Guo, Menglin Wang, Chunnuan Wu, Mengran Guo, Xiaoyu Ai, Yongjun   Wang, Zhonggui He. Docetaxel prodrug liposomes for tumor therapy:   characterization, in vitro and in vivo evaluation. Drug Delivery, 2016, 23   (4): 1272-1281.

社会兼职获

山西省药学会药剂学专业委员会委员









 

 


【关闭】